<DOC>
	<DOCNO>NCT02751398</DOCNO>
	<brief_summary>This study aim assess impact 24-week treatment dapagliflozin type 2 DM ( diabetes mellitus ) patient diastolic dysfunction . Primary endpoint assess impact 24-week treatment dapagliflozin type 2 DM patient subclinical diastolic dysfunction assess supine bicycle diastolic stress echocardiography . Secondary endpoint assess impact 24-week treatment dapagliflozin type 2 DM patient functional capacity , impact 24-week treatment dapagliflozin type 2 DM patient rest diastolic function . This single-center , randomize , double-blind , placebo-controlled , parallel-arm intervention study . This study plan evaluate impact dapagliflozin diastolic dysfunction assess . The dose dapagliflozin 10 mg approve . For assessment diastolic dysfunction , supine bicycle stress exercise echocardiography perform , change diastolic functional reserve , VO2max , exercise time , maximal exercise capacity assess treatment . This study randomize , double blind , placebo control , minimize risk bias .</brief_summary>
	<brief_title>Impact Dapagliflozin DIAstolic Dysfunction Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Female male age 19~75 year Type 2 DM reach adequate glycemic control stable dose metformin , sulfonylurea , drug screen HbA1c 7 % ~ 10 % screen Patients ≥ grade 1 diastolic function ( relaxation abnormality ) rest echocardiography Patients provide write , inform consent participate study Type 1 DM ( Fasting cpeptide ≤ 0.78ng/dL ( 0.26 nM/L ) ) , secondary diabetes , gestational diabetes History diabetic ketoacidosis , hyperglycemic hyperosmolar status Estimated glomerular filtration rate &lt; 60 mL/min/1.73m2 History chronic cystitis recurrent urinary tract infection Currently loop diuretic Currently medication know affect glucose metabolism ( e.g . corticosteroid , immunosuppressant ) Abnormal liver function ( AST/ALT &gt; x3 upper normal limit ) On weight loss program take weight loss medication LV ejection fraction &lt; 50 % rest echocardiography Uncontrolled hypertension ( systolic blood pressure &gt; 200mmHg and/or diastolic blood pressure &gt; 110mmHg ) History acute myocardial infarction , unstable angina , coronary artery bypass graft stroke within 6 month Inducible ECG abnormality exercise Cardiomyopathy , significant valvular heart disease , significant arrhythmia Patients perform supine bicycle stress echocardiography Pregnant lactate woman Subjects investigator deem inappropriate participate study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>